Molina Healthcare (MOH) PT Raised to $341 at Cowen

Cowen analyst Gary Taylor raised the price target on Molina Healthcare (NYSE: MOH) to $341.00 (from $336.00) while maintaining an Outperform rating.

The analyst commented, "We are updating our MOH model following 3Q21 results this week. We are slightly raising 2021/22/23 EPS from $13.41/16.88/19.88 to $13.33/17.00/19.81 to reflect slightly better pull-through of embedded earnings power vs headwinds of redeterminations and pharmacy carveouts. We are raising our PT from $336 to $341 (same 20x 2022 EPS). MOH remains an attractive “growth” idea in mid-cap managed care."

You May Also Be Interested In

• Designer Brands (DBI) PT Lowered to $6 at UBS
• Aon Corp (AON) PT Lowered to $360 at BMO Capital
• Aon Corp (AON) PT Raised to $417 at Keefe, Bruyette & Woods